For example, CDK1 was reported to interact with Sox2 and promote tumor initiation in human melanoma (Ravindran Menon et al., 2018), CCNA2 and AURKA inhibitors are now available and has shown encouraging effect for treatment of melanoma (Caputo et al., 2014; George et al., 2019). Here, AURKA is linked to melanoma.